Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health (ACH) reported Q2 2026 revenue of $613.2M, down from $681.9M YoY, and adjusted EBITDA of $60.1M, down from $96.6M. The company revised full-year revenue guidance to $2.45B-$2.55B and adjusted EBITDA to $300M-$320M, citing slower growth and collection rate issues. Total debt decreased by $385M to $1.72B. CEO Edward Pesicka announced his retirement by year-end.

Accendra Health (ACH) reported Q2 2026 net revenue of $613.2 million, down from $681.9 million a year earlier, and adjusted EBITDA of $60.1 million versus $96.6 million. Full-year revenue guidance was revised to $2.45 billion to $2.55 billion and adjusted EBITDA to $300 million to $320 million. Debt fell to $1.72 billion as of June 30, 2026.

Accendra Health (ACH) reported Q2 2026 revenue of $613.2 million, down from $681.9 million a year earlier, with GAAP net loss of $89.1 million ($1.16/share). Non-GAAP adjusted net loss was $14.3 million. Adjusted EBITDA fell to $60.1 million and free cash flow was -$25.1 million. The company guided FY2026 revenue $2.45-$2.55 billion and adjusted EBITDA $300-$320 million, and adopted a tax asset preservation plan.

ACCENDRA HEALTH INC/VA/ (ACH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622667d2_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accendra Health Reports Second Quarter 2026 Financial Results Reduced Total Debt By $385 Million In Second Quarter CEO Ed Pesicka Announces Intention To Retire By The End of 2026 RICHMOND, VA – August 10, 2026 – Accendra

Accendra Health Inc. (NYSE:ACH) said on June 23 it completed exchange offers for its 4.5% senior notes due 2029 and 6.625% senior notes due 2030. The notes were exchanged for new 9% senior secured first-lien notes due 2032 and 9.75% senior secured second-lien notes due 2033. Accendra expects to issue about $539.25 million first-lien notes and about $698.1 million second-lien notes, while S&P Global Ratings affirmed a 'B' issuer rating and moved outlook to stable.

Nancy Pelosi's spouse reportedly acquired 10,000 Intel shares and 50 call options, and 15,000 Bloom Energy shares and 200 call options in July. Intel reported Q2 revenue of $16.1B, up 25%, while Bloom Energy saw Q2 revenue surge 166% to $1.07B, raising full-year guidance to $3.9B-$4.2B.